Clincosm LogoSign in Get a demo

Metastatic Prostate Cancer

Showing 26 - 50 of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

Active, not recruiting
  • Prostate Cancer
  • +5 more
  • 131I-PSMA-1095 Radioligand Therapy (RLT)
  • Montreal, Quebec, Canada
    Stephan Probst
Oct 24, 2022

Metastatic Prostate Cancer, Recurrent Prostate Cancer Trial in Denmark, Estonia, Finland (Atorvastatin 80mg, Placebo oral

Recruiting
  • Metastatic Prostate Cancer
  • Recurrent Prostate Cancer
  • Atorvastatin 80mg
  • Placebo oral capsule
  • Herlev, Denmark
  • +9 more
Oct 19, 2022

Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +259 more
Oct 19, 2022

Metastatic Prostate Cancer Trial in Toronto (GA+M Intervention, RSM intervention, GA+RSM intervention)

Not yet recruiting
  • Metastatic Prostate Cancer
  • GA+M Intervention
  • +2 more
  • Toronto, Ontario, Canada
  • +1 more
Oct 12, 2022

Metastatic Prostate Cancer Trial in Toronto (Enzalutamide, Standard of Care SBRT and ADT)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Center
Oct 6, 2022

Metastatic Prostate Cancer, Neuroendocrine Prostate Cancer Trial in Detroit, New York, Lancaster (ORIC-944)

Recruiting
  • Metastatic Prostate Cancer
  • Neuroendocrine Prostate Cancer
  • Detroit, Michigan
  • +2 more
Sep 19, 2022

Testing Circulating Tumour DNA for Homologous Recombination Gene

Recruiting
  • Circulating Tumor DNA
  • Metastatic Prostate Cancer
  • Blood sample
  • Urine sample
  • Tours, France
    University hospital
Sep 6, 2022

Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-rosopatamb)

Not yet recruiting
  • Metastatic Prostate Cancer
  • 177Lu-DOTA-rosopatamb
  • (no location specified)
Aug 29, 2022

Prostate-Specific Membrane Antigen PET Scans in People Prostate

Recruiting
  • Prostate Cancer
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 29, 2022

Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

Enrolling by invitation
  • Prostate Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Metastatic Prostate Cancer Trial in Cleveland (Exercise therapy)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Exercise therapy
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 2, 2022

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,

Active, not recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • Duarte, California
  • +26 more
Aug 3, 2022

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco

Recruiting
  • Prostate Cancer
  • +2 more
  • Consultation audio recording app
  • San Francisco, California
    University of California, San Francisco
Jul 27, 2022

Predictive fActors for toleraNce to Taxane Based CHemotherapy In

Completed
  • Elderly Patients
  • Metastatic Prostate Cancer
  • Taxane chemotherapy
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jul 21, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

TowardComprehensive Supportive Care Intervention for Older or

Completed
  • Metastatic Prostate Cancer
  • Daily and weekly triggered symptom monitoring
  • Toronto, Ontario, Canada
  • +1 more
May 17, 2022

Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)

Active, not recruiting
  • Castration Resistant Prostatic Cancer
  • Metastatic Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
May 17, 2022

Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)

Active, not recruiting
  • Metastatic Prostate Cancer
  • [F-18] DCFPyL
  • PET/CT imaging
  • New York, New York
    Columbia University Irving Medical Center
May 6, 2022

Metastatic Prostate Cancer Trial in Saint-Grégoire (HYPNO VR® device)

Recruiting
  • Metastatic Prostate Cancer
  • HYPNO VR® device
  • Saint-Grégoire, France
    CHP Saint-Grégoire
May 9, 2022

Metastatic Prostate Cancer Trial in Sydney, Melbourne (Dasatinib, Darolutamide)

Recruiting
  • Metastatic Prostate Cancer
  • Sydney, New South Wales, Australia
  • +1 more
May 3, 2022

Androgen Deprivation-related Sarcopenia

Recruiting
  • Metastatic Prostate Cancer
  • Androgen Deprivation Therapy
  • GnRH agonist
  • Seattle, Washington
    Veterans Affairs Puget Sound Health Care System
Mar 16, 2022

Metastatic Prostate Cancer Trial in Birmingham ([68Ga]PSMA-PET/MRI or PET/CT)

Completed
  • Metastatic Prostate Cancer
  • [68Ga]PSMA-PET/MRI or PET/CT
  • Birmingham, Alabama
    University of Alabama at Birmingham Medical Center
Mar 7, 2022

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • High Intensity Interval Training
  • San Antonio, Texas
    UT Health San Antonio
Feb 17, 2022